Clinical Trial Update: GLS-5700 in Dengue Virus-Naïve Adults [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial of the dengue vaccine GLS-5700 in dengue virus-naïve healthy adults has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dengue

Drugs mentioned

• GLS-5700 (GLS-5700)

Snippet

Sponsor: GeneOne Life Science, Inc. | Conditions: Healthy | Phase 1 | Status: COMPLETED | Results posted: 2024-12-24